ATM and hematopoietic and lymphoid cell neoplasm: The age at the time of death in these 3 patients was not significantly different from other ATM-deficient patients with only- hematologic cancers (13.5 (IQR 8.6–19.5) vs. 14.7 (IQR 10.0–21.5) years, p = 0.62).